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For several years investigators have examined and characterized some of the
surface antigens of the bacterium Neisseria gonorrhoeae, including pili, lipopoly-
saccharide (LPS), and various proteins of the outer membrane (for review see
references 1 and 2) . The particular interest in our laboratory has been to
understand how all of the components within the gonococcal outer membrane
function to the advantage of the organism . In this effort, we have isolated and
purified members of the protein I family and found them to be trimeric
complexes that form voltage-dependent, anion-specific transmembrane porins
(3-5) . Furthermore, we have purified several members of the protein II family,
one of which confers the opaque phenotype to gonococcal colonies (6) whereas
another seems to be implicated in the association of gonococci with polymorpho-
nuclear leukocytes (7) . In order to complete our information about the outer
membrane proteins and help us understand how these protein components of
the gonococcal outer membrane might work in concert, we turned our attention
to the last remaining major outer membrane protein family, the reduction-
modifiable proteins, or proteins III .
Protein III is present in all strains of gonococci examined to date and differs
from the other surface-exposed gonococcal outer membrane proteins by its high
degree of intrastrain and interstrain homology in molecular weight, structure,
and immunology (8, 9) . These characteristics make protein III unique among
the major outer membrane antigens of the gonococcus, as proteins I and II, as
well as LPS and pili, all appear to display a considerable degree of variability
either within a strain or between strains (1, 2) . Because it has been hypothesized
that this variability was in part due to the immunologic pressure of the human
host, it was puzzling that gonococci would rigidlyconserve such a surface antigen .
For this reason it seemed that we should isolate and purify this protein in order
to study its biochemical and immunochemical nature in more detail . Thus, this
article will present a newly devised method of isolating and purifying protein III
and a partial characterization of the structure and immunochemistry of the
molecule based on our investigations that use the purified protein . The method
used for isolating protein III in large quantities is a simple refinement of the
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technique used to purify proteins I and II as described in a previous report (6).
The immunologic data obtained using protein III purified in this manner suggest
that the original structure of the molecule is in no way destroyed by the
purification process.
Materials and Methods
Bacteria and Culture Conditions.
￿
Most of the strains cited in this article have been
cultivated in our laboratory for several years. Strain Pgh 3-2 was generously provided
and used with the permission of Dr. Charles C. Brinton of the Department of Microbiol-
ogy, University of Pittsburgh. The one Neisseria meningitidis strain referred to here as
BNCV` is a group B nonencapsulated variant of strain M986, which was provided by Dr.
Carl E. Frasch of the Bureau of Biologics, Washington, D.C. The bacteria were grown on
solid typing medium defined by Swanson (10) and were identified as N. gonorrhoeae by
Gram's stain, oxidase reaction, and carbohydrate fermentation ability. Nonpiliated orga-
nismsof both opaque and transparent colonial phenotypes were used. However, it should
be noted that the protein III from the transparent variety was isolated with more ease.
For protein purification, the bacteria were grown in a liquid medium, the preparation
of which has been described previously (3). A typical purification started with 12 liters of
liquid medium dispersed in eight 2,800-ml Fernbach flasks. Each flask was inoculated
with a 50-ml late log phase culture of gonococci. The Fernbach flaskcultures were placed
in a Brunswick rotary shaking incubator (New Brunswick Scientific Co., Inc., Edison, NJ)
and incubated for 7 h at 37'C while shaking at 100 rpm. The bacteria were then harvested
by centrifugation at 17,000 gfor 10 min.
Purification.
￿
The harvested bacteria were extracted with 0.5 M CaCl2/5% Zwittergent,
N-tetradecyl-N,N-dimethyl-3-ammonia-l-propanesulfonate (Z3,14) as was described pre-
viously for the purification of the gonococcal opacity proteins (6). The precipitate that
resulted from this extraction was then slowly resuspended in an equal volume of 0 .65 M
ethanolamine-HCI, pH 10.4. To this was added 6 vol of 0.5 M CaC12/5% Z3,14 and
finally two volumes of absolute ethanol. This second extraction was then briefly sonicated
into a smooth suspension in a bath sonicator (Branson Cleaning Equipment Co., Shelton,
CT). The suspension was centrifuged at 17,000 g for 20 min. The supernatant was
removed and additional absolute ethanol was added to bring the final concentration of
ethanol to 80%, and the resultant precipitate was recovered by centrifugation. The
precipitate was dissolved in 50 mM Tris-HCI, pH 8 .0, 10 mM EDTA, and 5% Z3,14 and
clarified by centrifugation at 12,000 g for 10 min, and the soluble material was retained.
This solution was then applied to the first of two columns linked in tandem. The first
(2.5 X 10 cm) was packed with DEAE-Sepharose 6B-CL (Pharmacia Fine Chemicals,
Piscataway, NJ) and the second (0.9 X 10 cm) with CM-Sepharose 6B-CL (Pharmacia Fine
Chemicals). Both columns had been equilibrated previously with 50 mM Tris-HCl, pH
8 .0, with 10 mM EDTA and 0.05% Z3,14. The eluate from both columns was monitored
for proteins at 280 nm absorption. Afterthe sample was applied the columns were washed
with the equilibration buffer until the 280-nm absortion fell to baseline. The columns
were then separated and each eluted with a NaCl gradient between 0.0 and 0.5 M. The
totalvolume applied to the CM-Sepharose column was 60 ml. Fractions containing protein
by 280-nm absorption were analyzed by SDS-PAGE. The fractions containingthe protein
III were collected, pooled, and precipitated by the addition of ethanol to a final concen-
tration of 80% . The precipitate was collected by centrifugation and redissolved in the
Tris-HCI 5% Z3,14 buffer in -1-2 ml. This material was applied to a Sephacryl S-200
(Pharmacia Fine Chemicals) column (1 .5 X 100 cm). The elution buffer consisted of 100
mM Tris-HCI, 200 mM NaCl, 10 mM EDTA, 0.05% Z3,14 at pH 8 .0 and the flow rate
was 2 ml/h. Fractions of 2.0 ml were collected, monitored for 280 nm absorbance, and
analyzed by SDS-PAGE.
Abbreviations used in this paper:
￿
BNCV, group B nonencapsulated variant of strain M986 of N.
gonorrhoeae; Z3,14, Zwittergent, N-tetradecyl-NN-dimethyl-3-ammonia-l-propanesulfonate .LYTTON AND BLAKE
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Amino Acid Analysis.
￿
The amino acid composition was determined using a Durrum
model D500 amino acid analyzer (Beckman Instruments, Inc., Palo Alto, CA) as previously
described (3).
Determination of Amino-terminal Amino Acids.
￿
3 .0 mg of protein III was precipitated
with 10% trichloroacetic acid, and the precipitate was washed with ethanol and acetone.
The precipitate was then dissolved in 50% (vol/vol) acetic acid and introduced into a
model 890B sequenator (Beckman Instruments, Inc.).
SDS-PAGE. The extract procedure for sample preparation and the electrophoresis
have been described in detail elsewhere (3).
Isoelectric Focusing. The isoelectric point of protein III was determined using a
modification of the method of Rosen et al. (11), which has been previously described (6).
Enzyme Digestion.
￿
a-chymotrypsin (EC 3.4.21 .1) and trypsin (EC 3.4.21 .4; Worthing-
ton Diagnostics, Freehold, NJ) were dissolved in 1 mM HCI at a concentration of 1 mg/ml
and frozen in aliquots until used. 10 ug of each of the enzymes per mg of protein III was
added to separate tubes containing protein III and were incubated for 30 min at 37°C.
Trichloroacetic acid was added with a final concentration of 10% which stopped the
reaction. The samples were then processed for SDS-PAGE analysis as described.
Immunological Methods.
￿
Antisera to purified protein III were produced in the same
manner as that described for the purified protein II (6). The ELISA technique used was
also identical to that used previously (6). In the whole-cell absorption experiments, the
bacteria from a certain strain were removed from solid agar medium with a dacron swab
and suspended in sterile PBS. The organisms were then diluted with the PBS until the
optical density at 500 nm reached 0.6. This suspension was then dispensed into 0 .1-ml
aliquots and centrifuged, and the supernate was removed. The bacteria were resuspended
in 0.1 ml of the appropriate dilution of antiserum and incubated for 30 min at 4 °C. The
bacteria were then removed by centrifugation and the supernate was either applied
directly to the ELISA plate or placed into a fresh aliquot of organisms and reabsorbed.
Purification
Results
CaCl2/Z3,14 extraction.
￿
As described in a previous article (6), a solution of
5% Z3,14 in 0.5 M CaC12 solubilized several of the gonococcal outer membrane
proteins when added to a suspension of bacteria. Because it was virtually impos-
sible to separate protein I from protein III in a single extraction procedure, two
such CaC12/Z3,14 extractions conducted at different pHs were required. The
first extraction carried out at pH 4.0 released protein I and, when present,
protein 11 from the outer membrane, while leaving protein III still associated
with the membrane in the ethanol-precipitable fraction. When the pH was
subsequently raised to 10.4 in the second extraction, protein III was solubilized .
The solubilized fraction of the second CaC12/Z3,14 extraction containing protein
III was prepared for ion-exchange chromatography by ethanol precipitation and
resuspension in Tris-140, 5% Z3,14 buffer.
Ion-exchange chromatography.
￿
Upon chromatographing the protein III suspen-
sion on two ion-exchange columns linked together, it was found that protein III
bound to the CM-Sepharose column. This isolated the protein from any residual
nucleic acids not removed during the two extraction procedures, inasmuch as
the nucleic acids adhered to the DEAE-Sepharose CL-6B column. Using a NaCl
gradient from 0 .0 to 0 .5 M NaCl, protein III was eluted from the CM-Sepharose
column in one peak between 6.4 and 7 .4 mS as shown in Fig. 1 .
Molecular sieve chromatography. Protein III eluted from a Sephacryl S-200
column (1 .5 x 100 cm) in a single peak with a Ka,, of 0 .302 (Fig. 2). Thus the M,1752 GONOCOCCAL REDUCTION-MODIFIABLE PROTEIN
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FIGURE 1 .
￿
Elution profile ofgonococcal protein III from a CM-Sepharose column (0 .9 X 10
cm). The sample was applied in a buffer consisting of 50 mM Tris-HCI, pH 8.0, 10 mM
EDTA, and 5% Z3,14. The column was washed with the same buffer with 0.05% Z3,14 until
the A280 fell to zero. The column was eluted with a NaCl gradient between 0.0 and 0.5 M.
The elution was monitored by absorbance at 280 nm (solid line), conductivity (dashed line),
and SDS-PAGE analysis. Protein III eluted from the column between 6.4 and 7.4 mS. The
fractions containing protein III were collected andpooled.
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FIGURE 2.
￿
Protein III eluted from a Sephacryl S-200column (1 .5 X 100 cm) with a -Ka of
0.302. The elution buffer consisted of 0.1 M Tris-HCI, pH 8.0, 0.2 M NaCI, and 0.05%
Z3,14. The elution was monitored by absorbance at 280 nm (solid line) and SDS-PAGE
analysis. Fractionscontaining protein III were collected and pooled.
of the protein III-Zwittergent micelle complex was calculated as being ^x46,000.
The protein profile upon SDS-PAGE analysis showed that the fractions in the
elution peak contained essentially pure protein and that the protein was indeedLYTTON AND BLAKE
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FIGURE 3 .
￿
SDS-PAGE analysis ofthe purified protein III with 2-ME (lane 2) and without 2-
ME (lane 3) . Note that the purified protein maintains its modifiability . Lanes 1 and 4 contain
the molecular weight standards: carbonic anhydrase (30,000) and soy bean trypsin inhibitor
(21,500) .
protein III, inasmuch as it exhibited the characteristic reduction-modifiability of
that protein (Fig . 3) .
Isoelectric Focusing
Using an agarose gel system of isoelectric focusing with apH gradient of 7.0-
10.0, it was found that protein III focused at apH of ^-8.6 .
Amino Acid Analysis
As Table I indicates, protein III, like protein II, appears to contain more basic
amino acids than does protein I, thus confirming the data obtained from ion-
exchange chromatography and isoelectric focusing as to the basic nature of
protein III. Also of particular interest are the two half-cystines, which could
account for the variable migratory characteristics of protein III on SDS-PAGE
in the presence or absence of 2-ME .
Amino-terminal Determination
Purified proteins III from two different gonococcal strains, Pgh 3-2 and R10,
were precipitated with 10% trichloroacetic acid, and theprecipitates were washed
with ethanol and acetone and were then applied into a model 890B sequenator
(Beckman Instruments, Inc., Fullerton, CA) in 50% acetic acid . The first 10
amino acids of the amino termini of both samples proved to have the identical
sequence, as shown in Fig. 4 . The purity of the sequence was>99% .
Proteolytic Enzyme Treatment
Samples of purified protein III were incubated separately with trypsin and a-
chymotrypsin, and these preparations were then subjected to SDS-PAGE . In
both cases, the protein appeared to be completely degraded, thus indicating
extreme susceptibility to digestion by these endopeptidases .
Immunological Properties
All rabbits inoculated with purified protein III of one strain produced anti-
bodies that reacted with the homologous purified protein III that was bound to
the polystyrene in an ELISA assay . In addition, all rabbits injected with whole
bacteria alsoproduced antibodies to purified protein III as determined byELISA .
Western blot analysis in which a whole cell lysate of the homologous strain was1754
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TABLE I
Amino Acid Composition ofGonococcal Protein III
* Number of moles of residue per mole of protein.
$ Fraction of total number of residues represented in each class.
Strain
￿
5
￿
10
R10(pIII) Gly-Glu-Ala-Ser-Val-Gln-Gly-Tyr-XXX-Val
Pgh 3-2(pill)
￿
Gly-Glu-Ala-Ser-Val-Gln-Gly-Tyr-XXX-Val
FIGURE 4.
￿
Amino-terminai amino acid sequence of gonococcal protein III.
reacted with antiserum raised againstthepurified proteinshowed that the protein
isolated and purified by the method outlined above was indeed protein III, in
that a very strong reaction with the antiserum was demonstrated by the 31,000
mol wt (reduced protein III) band. Western blot analysis using the same immune
rabbit serum against whole-cell lysates of several different strains of gonococci,
one group B nonencapsulated variant of N. meningitidis (BNCV), and one strain
of N. sicca revealed a very high degree of crossreactivity among the proteins III
of all strains of gonococci as well as with the class 4 (reduction-modifiable) protein
of BNCV. No significant reactivity was detected for any protein of N. sicca (Fig.
5). Sequential absorptions of rabbit antiserum raised against purified protein III
by homologous and heterologous whole gonococci and by BNCV confirmed this
finding, because all of the strains tested exhibited considerable reactivity with
the immune serum and almost identical patterns of absorption. These studies
Amino acids Residue* (fraction)*
mol
Neutral 175 (0.63)
Aliphatic 138 (0.49)
Glycine 20
Alanine 34
Valine 29
Leucine 17
Isoleucine 9
Serine 18
Threonine 11
Aromatic 15 (0.05)
Phenylalanine 7
Tyrosine 8
Tryptophan -
Sulfur-containing 6(0.02)
Halfcystine 2
Methionine 4
Iminoacids/proline 16 (0.06)
Dicarboxylic aminoacids 63 (0.22)
Aspartic/asparagine 26
Glutamic/glutamine 37
Basic amino acids 41 (0.15)
Histidine 4
Arginine 20
Lysine 17
Total 279LYTTON AND BLAKE
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FIGURE 5.
￿
Western blot analysis of whole-cell lysatesfrom several different strains of gono-
cocci (lane 1, B2 ; lane 2, MAN 851; lane 3, MS11 ; lane 4, R10 ; lane 5, Pgh 3-2 ; lane 6, UU1 ;
lane 7, 120176-2), one strain of meningococcus (lane 8, BNCV), and oneN . sicca strain (lane
9) . Hyperimmune rabbit serum raised against purified protein III was allowed to react with
the proteins on the blot and these rabbit antibodies detected with a goat anti-rabbit alkaline
phosphatase-conjugated antibody as described in MaterialsandMethods . Note that the protein
detected by this antiserum is of identical molecular weight in each of the gonococcal strains .
A protein of slightly higher molecular weight is detected in the meningococcal strain . No
distinct reactive protein was found in the sicca lysate .
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FIGURE 6 . Absorptions of hyperimmune protein III antiserum by whole organisms (as
described in Materials and Methods) . The percentage of maximum reactivity was arrived at
by taking the ELISAreading at 405 nm of an aliquot of antiserum that had been absorbed by
whole cellsand dividing it by the reading of an aliquot that hadnotbeen incubated with cells .
Note the very rapid decline in reactivity in the first two to three cycles ofabsorption ; thereafter,
the reactivity declines much less rapidly. Also note that each of the four strains of gonococci
absorb the hyperimmune antiserum raised against the purified protein III of Pgh 3-2 .
also provided convincing evidence that protein III is indeed exposed on the
surface of the outer membrane, in that the curves in Fig . 6 display a leveling off
above baseline at later absorptions, a characteristic of partially surface-exposed
antigens .
When the unreduced and reduced forms of protein III were compared by
both Western blot analysis and ELISA, rabbit antiserum raised against protein1756
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III appeared to react more strongly with the reduced protein. However, in an
inhibition assay in which the antiserum was allowed to react with both reduced
and unreduced protein III before exposure to the reduced protein that was
bound to the polystyrene of a microtiter plate, the antiserum mixed with the
reduced and with the unreduced protein III reacted virtually identically with the
reduced protein on the plate, and the decrease in inhibition by the reduced form
of protein III seen in the first assay was not observed. Therefore, the state of
reduction of protein III does not appear to affect the immunogenicity of the
protein.
Discussion
Our investigations using protein III purified by the method outlined above
have provided new information regarding the structural and antigenic nature of
this molecule and also served to confirm or clarify certain earlier hypotheses
about the protein. We have demonstrated that protein III constitutes a discrete
family ofgonococcal outer membrane proteins that differs markedly from either
protein I or protein II. We havealso confirmed that protein III is unique among
all outer membrane constituents in its extremely high degree ofbiochemical and
immunogenic homogeneity. Whereas pili, LPS, and proteins I and II all vary
considerably in their structure and behavior between and/or within strains,
protein III exhibits little if any such variability. Furthermore, data obtained
using rabbit antiserum raised to purified protein III have provided evidence that
this reduction-modifiable molecule may be conserved in other Neisseria species
as well.
In our efforts to purify protein III, we found it essential to perform two
separate extraction procedures (versus the one extraction required for the
purification ofprotein I and protein II). Earlier crosslinkingand immunoprecip-
itation studies have indicated that protein I and protein III are very closely
associated in vivo in the gonococcal outer membrane (12, 13), and as we
discovered, it was virtually impossible to separate the two proteins from each
other with only one extraction step. However, by performing the first extraction
at a low pH, we succeeded in dissociating protein I from protein III and releasing
protein I from the membrane. Raising the pH for the second extraction released
protein III. It is unclear as to exactly why lowering the pH in the first extraction
step disrupts the natural association ofproteins I and III within the membrane.
Based on the isoelectric points of the two proteins, it seems unlikely that the
association of the two proteins is due to an ionic interaction. It is possible,
however, that the reduction in pH alters the tertiary structure ofeither protein
I or protein III, or both, in such a way as to interfere significantly with
hydrophobic interactions between the two molecules.
Two unusual observations made during our investigations using purified
protein III were (a) the unexpected behavior of protein III on gel filtration
chromatography and (b) the different susceptibility to enzymatic degradation of
protein III in the intact membrane and in its purified state. Unlike proteins I
and II, which elute off molecular sieve columns at their predicted molecular
weights, protein III eluted off the Sephacryl S-200 at a significantly lower Ka,,
than expected. Based on its apparent molecular weight of30,000 by SDS-PAGE,LYTTON AND BLAKE
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the estimated size of protein III plus its Zwittergent micelle would be around
90,000 mol wt. Instead, we found that the protein-micelle complex migrated
through the S-200 at the much lower molecular weight of 46,000 . It would
appear then that protein III interacts with the detergent molecules in a highly
irregular manner; perhaps the detergent molecules associate with protein III in
only a partial or intermittent way rather than forminga complete micelle around
the protein. Apossible interpretation of this data might be that protein III may
contain only a very small hydrophobic region that is embedded in the lipid
leaflets of the outer membrane, whereas the majority of the molecule, perhaps
as much as two thirds, is hydrophilic and extends into the periplasm or past the
outer surface of the membrane.
Earlier data obtained from proteolytic digests ofwhole gonococci and ofouter
membrane preparations suggest that very little if any of protein III is exposed
on the surface of the bacterium, as no degradation of the protein is observed
when analyzed by SDS-PAGE (14). This is in complete contrast to the results
obtained when the purified protein is exposed to the same endopeptidases. The
protein is degraded so completely by both trypsin and a-chymotrypsin that no
peptides whatsoever could be seen on SDS-PAGE. These data would seem to
indicate that protein III is not exposed on the surface of the outer membrane.
Despite its apparent resistance to proteolysis in the intact membrane, our im-
munoabsorption studies clearly confirmed that at least some portion of the
molecule is surface exposed, inasmuch as after several sequential absorptions
with immune serum raised against protein III, a large amount of antibody
reactivity is removed.
Two possible models for the orientation ofprotein III in the outer membrane
could account for these observations, i.e., the protein's irregular behavior on gel
filtration chromatography, its insusceptibility to enzymatic digestion in the intact
membrane, its surface exposure, and its absorption patterns. One is that protein
III might be embedded in the membrane in such a way that a large portion of
the molecule extends out past the surface while a smaller hydrophilic portion
extends into the periplasmic space. This model would seem to account well for
the absorption data, because the majority of anti-protein III antibodies are
absorbed out ofthe immune serum by the whole bacteria leaving a much smaller
amount that still reacted with the purified protein on the microtiter plate (Fig.
6). This interpretation raises the question, however, of how so large a part of
the protein can be exposed on the surface and yet be (a) insusceptible to at least
some enzymatic degradation and (b) so highly conserved in light of the immu-
nologic pressures to which it would be constantly exposed.
A second model might be that only a small segmentofthe protein III molecule
is exposed on the outer surface ofthe membrane while the larger portion would
extend into the periplasm. This would be more consistent with the enzymatic
digestion data, because a small segment of a protein might not contain any
trypsin or chymotrypsin sites. Italso might fit the absorption data if one assumes
that the shorter, exposed segment is more immunogenic than the larger unex-
posed portion and that there are a large number of protein III molecules on the
surface of the gonococcus.
Recent work by Gotschlich et al. has resulted in the cloning of the gene for1758
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gonococcal protein III . The DNA sequencing of this gene in the near future
should provide much valuable information regarding the primary structure of
the protein and further insight into the conformation, orientation, and antigen-
icity of protein III .
Given the high degree of structural and antigenic conservation of protein III
and its known exposure on the surface of the outer membrane, the question
arises as to how such an unvarying surface-exposed antigen could be of value to
a pathogenic organism faced with the constant immune pressures of a host. This
in turn raises the question as to the possible funtion(s) of protein III . Recent
investigations by Rice et al. (15) may provide the answers to both of these
questions. Using purified protein III isolated by our method, they have been
able to demonstrate that protein III constitutes a major antigenic determinant
for raising blocking antibodies in normal human sera that inhibit the efficient
insertion into the bacterial membrane of the C5b-9 complement complex . If this
hypothesis is correct, the immunogenic constancy of protein III becomes ex-
tremely beneficial to the gonococcus.
Summary
We have isolated and purified the reduction-modifiable protein (protein III)
from several strains of Neisseria gonorrhoeae. We have found them to be basic
proteins (pI 8 .6) and virtually identical. A similar but not identical protein was
isolated from a meningococcal strain . Antibodies raised against this purified
protein would absorb to whole bacteria, confirming that the protein is exposed
on the surface of the organism.
Received for publication 30 June 1986.
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